6 completed, 3 terminated. 7 Phase 4, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 5, Terminated 2 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Osiris Therapeutics: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cryopreserved vs. Lyopreserved Stravix as an Adjunct to NPWT in the Treatment of Complex Wounds NPWT and lyopreserved Stravix, NPWT and cryopreserved Stravix - Diabetic Wound | Phase 4 | Completed | University of Texas Southwestern Medical Center | 46 | 2021-06-22 | 2023-07-24 |
| GrafixPL PRIME Evaluation Case Study GrafixPL PRIME - Diabetic Foot Ulcer | Phase 4 | Completed | University of Texas Southwestern Medical Center | 40 | 2018-11-20 | 2023-07-24 |
| Study to Evaluate Safety and Efficacy of GrafixPL for the Treatment of Venous Leg Ulcers GrafixPL, Control - Venous Leg Ulcer | Not applicable | Completed | Osiris Therapeutics | 200 | 2018-06-27 | 2022-04-12 |
| TruSkin®: Study for Treatment of Chronic Venous Leg Ulcers TruSkin, Wound Cover - Chronic Venous Leg Ulcers | Phase 4 | Terminated | Osiris Therapeutics | 7 | 2016-07-01 | 2017-04-06 |
| TruSkin®: Study for the Treatment of Chronic Diabetic Foot Ulcers TruSkin®, Wound Cover - Diabetic Foot Ulcers | Phase 4 | Terminated | Osiris Therapeutics | 14 | 2016-07-01 | 2017-04-06 |
| GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers GrafixPRIME®, Dressing Application, Off-loading (walking boot) - Foot Ulcer, Diabetic | Phase 4 | Completed | Osiris Therapeutics | 75 | 2016-01-01 | 2017-07-17 |
| Study to Evaluate the Safety and Efficacy of CHAM* for the Treatment of Diabetic Foot Ulcers CHAM, Control - Chronic Diabetic Foot Ulcers | Phase 3 | Terminated | Osiris Therapeutics | 108 | 2015-10-01 | 2017-10-06 |
| GrafixCORE®: Open-Label Study to Evaluate the Safety and Efficacy of GrafixCORE® for Complex Diabetic Foot Wounds Grafix® - Complex Diabetic Foot Wounds | Phase 4 | Completed | Osiris Therapeutics | 31 | 2014-10-01 | 2016-02-02 |
| Grafix® DFU: Open-Label Extension Option to Evaluate Safety & Efficacy of Grafix® for Chronic Diabetic Foot Ulcers Tissue, Control - Diabetic Foot Ulcers | Phase 4 | Completed | Osiris Therapeutics | 97 | 2012-04-01 | 2014-04-09 |
Diabetic Foot (5) · Varicose Ulcer (1)
Histocompatibility Testing (2) · Negative-Pressure Wound Therapy (1)
United States (9)
Lawrence Lavery, DPM MPH (2) · Jaideep Banerjee, PHD (1) · Sharron E McCulloch (1) · Sharron McCulloch (1)